| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. | Chief Legal Officer | Common Stock | 150K | $1.73M | $11.54 | Feb 2, 2024 | Direct |
| Zentalis Pharmaceuticals, Inc. | Chief Legal Officer | Stock Option (Right to Buy) | 90K | Feb 1, 2024 | Direct | ||
| LogicBio Therapeutics, Inc. | General Counsel and Secretary | Stock Option (right to buy) | 80K | Mar 1, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals, Inc. | Feb 1, 2024 | 4 | -$38.2K | 4 | Feb 5, 2024 | Chief Legal Officer |
| ZNTL | Zentalis Pharmaceuticals, Inc. | Feb 1, 2023 | 2 | $0 | 4 | Feb 1, 2023 | General Counsel |
| ZNTL | Zentalis Pharmaceuticals, Inc. | Aug 1, 2022 | 1 | $0 | 4 | Aug 1, 2022 | General Counsel |
| ZNTL | Zentalis Pharmaceuticals, Inc. | Aug 1, 2022 | 0 | $0 | 3 | Aug 1, 2022 | General Counsel |
| LOGC | LogicBio Therapeutics, Inc. | Mar 1, 2022 | 1 | $0 | 4 | Mar 3, 2022 | General Counsel and Secretary |
| LOGC | LogicBio Therapeutics, Inc. | May 17, 2021 | 1 | $0 | 4 | May 19, 2021 | General Counsel and Secretary |
| LOGC | LogicBio Therapeutics, Inc. | May 17, 2021 | 0 | $0 | 3 | May 19, 2021 | General Counsel and Secretary |